GlycoMimetics

GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.

Stock Movers

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ADTX

APTO

CSAI

DSGN

EFOI

EWCZ

GLYC

GRAB

HEES

INLF

LVWR

MGOL

MTRX

NESR

NTIC

RSLS

TNMG

Why GCL Global Holdings Shares Are Trading Higher By Around 107%; Here Are 20 Stocks Moving Premarket

Alphabet.Google.Shutterstock

AMBO

DBGI

ENSC

GOOG

GOOGL

LGMK

NRDS

PLRZ

QRVO

RDDT

RHHBY

SHPH

SNAP

SPRO

STBX

THRY

Tempest Therapeutics, Inc. - Common Stock

TPST

Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket

Record High Gold Prices

Earnings

Equities

Eurozone

Commodities

BKYI

EFSH

TMDX

Gold Gains 1%; Phillips 66 Shares Fall After Q3 Results

GlycoMimetics Inc

Legal

Press Releases

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFIE, CPTN, GLYC, ARC on Behalf of Shareholders

Kuehn Law Encourages PFIE, GLYC, RVNC, and RCM Investors to Contact Law Firm

GLYCOMIMETICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of GlycoMimetics, Inc. - GLYC

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, ALTR, GLYC on Behalf of Shareholders

INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. - GLYC

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALTR, PFIE, GLYC on Behalf of Shareholders

GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZUO, PFIE, GLYC on Behalf of Shareholders

Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024

Health Care

Crescent Biopharma to Present at the TD Cowen 45th Annual Health Care Conference

ALTR

CPTN

PFIE

RVNC

USAP

ABVC BioPharma

Acurx Pharmaceuticals, Inc. - Common Stock

Acurx Pharmaceuticals

BioAtla

Bolt Biotherapeutics, Inc. - Common Stock

Bolt Biotherapeutics

Carisma Therapeutics, Inc. - Common Stock

CARISMA Therapeutics

CervoMed

Eterna Therapeutics

HCW Biologics

HOOKIPA Pharma

IN8bio

Kairos Pharma

Leap Therapeutics

Lisata Therapeutics

MEI Pharma

Marker Therapeutics

NKGen Biotech

Nanoviricides

NextCure

Ocean Biomedical

SAB Biotherapeutics

Senti Biosciences

Spruce Biosciences

Synlogic

TC BioPharm (Holdings) plc - American Depositary Shares

TC BioPharm (Holdings)

Tenax Therapeutics

Capital One

Comments

GlycoMimetics

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga